Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies

Veterinary Immunology and Immunopathology

Volumn 111, Issue 1-2, 2006, Pages 81-95

  Soboll, G ^a   Hussey, S B ^a   Whalley, J M ^b   Allen, G P ^c   Koen, M T ^b   Santucci, N ^b   Fraser, D G ^d   Macklin, M D ^e   Swain, W F ^e   Lunn, D P ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b MACQUARIE UNIVERSITY   (Australia)

^c UNIVERSITY OF KENTUCKY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

^e PowderJect Vaccines Inc   (United States)

Author keywords

CTL; DNA vaccination; EHV 1; Horses

Indexed keywords

DNA VACCINE; GLYCOPROTEIN; GLYCOPROTEIN B; GLYCOPROTEIN D; PLASMID DNA; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DEVICE; EQUINE ABORTION HERPETOVIRUS; EQUINE HERPES VIRUS; FEMALE; HORSE; MALE; NONHUMAN; VACCINATION; VIREMIA; VIRUS GENE; VIRUS INFECTION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; FEMALE; GENES, IMMEDIATE-EARLY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS VACCINES; HORSE DISEASES; HORSES; IMMUNOGLOBULIN IDIOTYPES; MALE; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRUS LATENCY;

ANIMALIA; EQUID HERPESVIRUS 1; EQUIDAE; EQUUS CABALLUS; HERPESVIRIDAE;

EID: 33645990644     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.01.011     Document Type: Article

References (62)

1. Allen G.P., Kydd J.H., Slater J.D., and Smith K.C. Advances in understanding of the pathogenesis, epidemiology, and immunological control of equid herpesvirus abortion. In: Wernery U., Wade J.F., Mumford J.A., and Kaaden O.-R. (Eds). Equine Infectious Diseases VIII. Proceedings of the Eighth International Conference, Dubai 23-26 March, 1998 (1999), R & W Publications, Newmarket 129-146
2. Allen G.P., Yeargan M., Costa L.R., and Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69 (1995) 606-612
3. Allen G.P., and Yeargan M.R. Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J. Virol. 61 (1987) 2454-2461
4. Antczak D.F. The major histocompatibility complex of the horse. In: Plowright W., Rossdale P.D., and Wade J.F. (Eds). Equine Infectious Diseases IV. Proceedings of the Sixth International Conference, Cambridge 1991 (1992), R & W Publications, Newmarket 99-112
5. Audibert F.M., and Lise L.D. Adjuvants: current status, clinical perspectives and future prospects. Trends Pharmacol. Sci. 14 (1993) 174-178
6. Bailey E., Antczak D.F., Bernoco D., Bull R.W., Fister R., Guerin G., Lazary S., Matthews S., McClure J., and Meyer J. Joint Report of the Second International Workshop on Lymphocyte Alloantigens of the Horse, 3-8 October 1982, vol. 15. Animal Blood Groups & Biochemical Genetics (1984) 123-132
7. Bailey E., Marti E., Fraser D.G., Antczak D.F., and Lazary S. Immunogenetics of the horse. In: Bowling A.T., and Ruvinsky A. (Eds). The Genetics of the Horse (2000), CABI Publishing, New York 123-155
8. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
9. Bhardwaj N., Bender A., Gonzalez N., Bui L.K., Garrett M.C., and Steinman R.M. Stimulation of human anti-viral CD8+ cytolytic T lymphocytes by dendritic cells. Adv. Exp. Med. Biol. 378 (1995) 375-379 (review)
10. Bodo G., Marti E., Gaillard C., Weiss M., Bruckner L., Gerber H., and Lazary S. Association of the immune response with the major histocompatibility complex of the horse. In: Nakajima H., and Plowright W. (Eds). In Equine Infectious Diseases VII (1994), R & W Publications, Newmarket 143-152
11. Borchers K., and Slater J. A nested PCR for the detection and differentiation of EHV-1 and EHV-4. J. Virol. Methods 45 (1993) 331-336
12. Breathnach C.C., Yeargan M.R., Sheoran A.S., and Allen G.P. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet. J. 33 (2001) 651-657
13. Bryans J.T., and Allen G.P. Herpesviral diseases of the horse. In: Wittmann G. (Ed). Herpesvirus Diseases of Cattle, Horses, and Pigs (1989), Kluwer Academic Publishers, Boston 176-229
14. Burki F., Rossmanith W., Nowotny N., Pallan C., Mostl K., and Lussy H. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Q. 12 (1990) 80-86
15. Chong Y.C., and Duffus W.P. Immune responses of specific pathogen free foals to EHV-1 infection. Vet. Microbiol. 32 (1992) 215-228
16. Cohen J. Naked DNA points way to vaccines. Science 259 (1993) 1691-1692
17. Crabb B.S., Allen G.P., and Studdert M.J. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies. J. Gen. Virol. 72 (1991) 2075-2082
18. Crabb B.S., MacPherson C.M., Reubel G.H., Browning G.F., Studdert M.J., and Drummer H.E. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch. Virol. 140 (1995) 245-258
19. Doll E.R., Crowe M.E.W., Bryans J.T., and McCollum W.H. Infection immunity in equine virus abortion. Cornell Vet. 45 (1955) 387-410
20. Edington N., Welch H.M., and Griffiths L. The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet. J. 26 (1994) 140-142
21. Ellis J.A., Bogdan J.R., Kanara E.W., Morley P.S., and Haines D.M. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses. J. Am. Vet. Med. Assoc. 206 (1995) 823-832 (see comments)
22. Flowers C.C., Flowers S.P., Sheng Y., Tarbet E.B., Jennings S.R., and O'Callaghan D.J. Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus. Virus Res. 35 (1995) 17-34
23. Fu T.M., Guan L., Friedman A., Schofield T.L., Ulmer J.B., Liu M.A., and Donnelly J.J. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 162 (1999) 4163-4170
24. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17 (1995) 79-83 (review)
25. Gallichan W.S., and Rosenthal K.L. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J. Exp. Med. 184 (1996) 1879-1890
26. Gibson J.S., Slater J.D., Awan A.R., and Field H.J. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch. Virol. 123 (1992) 351-366
27. Giese M., Bahr U., Jakob N., Kehm R., Handermann M., Mueller S.N., Vahlenkamp T., Spies T., Schneider T., Schusser G., and Darai G. Stable and long-lasting immune responses in horses after DNA vaccination against equine arteritis virus. Virus Genes 25 (2002) 159-167
28. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., and Love D.N. Epidemiological studies of equine herpesvirus 1 (EHV-1) in thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet. Microbiol. 68 (1999) 15-25
29. Gilkerson J.R., Whalley J.M., Drummer H.E., Studdert M.J., and Love D.N. Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals. Vet. Microbiol. 68 (1999) 27-34
30. Hassett D.E., and Whitton J.L. DNA immunization. Trends Microbiol. 8 (1996) 307-312
31. Koen M.T., Walker C., Wellington J.E., Love D.N., and Whalley J.M. Characterisation of IE and UL5 gene products of equine herpesvirus 1 using DNA inoculation of mice. Arch. Virol. 145 (2000) 2677-2686
32. Kukreja A., Love D.N., Whalley J.M., and Field H.J. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model. Vet. Microbiol. 60 (1998) 1-11
33. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., and Mumford J.A. Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet. J. 26 (1994) 470-473
34. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., and Mumford J.A. Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Vet. J. 26 (1994) 466-469 (see comments)
35. Kydd J.H., Wattrang E., and Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 96 (2003) 207-217
36. Ludewig B., Ehl S., Karrer U., Odermatt B., Hengartner H., and Zinkernagel R.M. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 72 (1998) 3812-3818
37. Lunn D.P., Holmes M.A., Antczak D.F., Baker J.M., Bendali-Ahcene S., Blanchard-Channell M., Byrne K.M., Cannizzo K., Davis W., Hamilton M.J., Hannant D., Kondo T., Kydd J.H., Monier M.C., Moore P.F., Neeraj N., Schram B.R., Sheoran A.S., Stott J.L., Sugiura T., and Vagnoni K.E. Report of the Second Equine Leucocyte Antigen Workshop. Vet. Immunol. Immunopathol. 62 (1998) 101-143
38. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R., Macklin M.D., McCabe D.E., Swain W.F., and Olsen C.W. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 17 (1999) 2245-2258
39. Mumford J.A., Rossdale P.D., Jessett D.M., Gann S.J., Ousey J., and Cook R.F. Serological and virological investigations of an equid herpesvirus 1 (EHV-1) abortion storm on a stud farm in 1985. J. Reprod. Fertil. Suppl. 35 (1987) 509-518
40. Munro K.I., Wellington J.E., Love D.N., and Whalley J.M. Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus. Vet. Microbiol. 68 (1999) 49-57
41. O'Neill T., Kydd J.H., Allen G.P., Wattrang E., Mumford J.A., and Hannant D. Determination of equid herpesvirus 1-specific, D8+ cytotoxic T lymphocyte precursor frequencies in ponies. Vet. Immunol. Immunopathol. 70 (1999) 43-54
42. Oehen S., Hengartner H., and Zinkernagel R.M. Vaccination for disease. Science 251 (1991) 195-198
43. Olsen C.W., McGregor M.W., Dybdahl-Sissoko N., Schram B.R., Nelson K.M., Lunn D.P., Macklin M.D., Swain W.F., and Hinshaw V.S. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine 15 (1997) 1149-1156
44. Osterrieder N., Wagner R., Brandmuller C., Schmidt P., Wolf H., and Kaaden O.R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208 (1995) 500-510
45. Packiarajah P., Walker C., Gilkerson J., Whalley J.M., and Love D.N. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Vet. Microbiol. 61 (1998) 261-278
46. Rouse R.J., Nair S.K., Lydy S.L., Bowen J.C., and Rouse B.T. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68 (1994) 5685-5689
47. Ruitenberg K.M., Love D.N., Gilkerson J.R., Wellington J.E., and Whalley J.M. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet. Microbiol. 76 (2000) 117-127
48. Ruitenberg K.M., Walker C., Love D.N., Wellington J.E., and Whalley J.M. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice. Vaccine 18 (2000) 1367-1373
49. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., and Whalley J.M. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Vaccine 17 (1999) 237-244
50. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., and Whalley J.M. Potential of DNA-mediated vaccination for equine herpesvirus 1. Vet. Microbiol. 68 (1999) 35-48
51. Siedek E.M., Whelan M., Edington N., and Hamblin A. Equine herpesvirus type 1 infects dendritic cells in vitro: stimulation of T lymphocyte proliferation and cytotoxicity by infected dendritic cells. Vet. Immunol. Immunopathol. 67 (1999) 17-32
52. Smith P.M., Zhang Y., Jennings S.R., and O'Callaghan D.J. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. J. Virol. 72 (1998) 5366-5372
53. Soboll G., Horohov D.W., Aldridge B.M., Olsen C.W., McGregor M.W., Drape R.J., Macklin M.D., Swain W.F., and Lunn D.P. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet. Immunol. Immunopathol. 94 (2003) 47-62
54. Soboll G., Nelson K.M., Leuthner E.S., Clark R.J., Drape R., Macklin M.D., Swain W.F., Olsen C.W., and Lunn D.P. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine 21 (2003) 3081-3092
55. Soboll G., Whalley J.M., Koen M.T., Allen G.P., Fraser D.G., Macklin M.D., Swain W.F., and Lunn D.P. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J. Gen. Virol. 84 (2003) 2625-2634
56. Stokes A., Alber D.G., Cameron R.S., Marshall R.N., Allen G.P., and Killington R.A. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. Virus Res. 44 (1996) 97-109
57. Tewari D., Whalley J.M., Love D.N., and Field H.J. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75 (1994) 1735-1741
58. van Der Meulen K.M., Nauwynck H.J., Buddaert W., and Pensaert M.B. Replication of equine herpesvirus type 1 in freshly isolated equine peripheral blood mononuclear cells and changes in susceptibility following mitogen stimulation. J. Gen. Virol. 81 (2000) 21-25
59. Walker, C., Ruitenberg, K., Wellington, J., Whalley, J.M., Love, D.N., 1997. Genetic immunization with equine herpesvirus-1 glycoprotein D. First International Veterinary Vaccines and Diagnostics Conference, Madison, Wisconsin, July 1997, p. 93.
60. Wellington J.E., Lawrence G.L., Love D.N., and Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141 (1996) 1785-1793
61. Wellington J.E., Love D.N., and Whalley J.M. Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion. Arch. Virol. 141 (1996) 167-175
62. Whalley J.M., Love D.N., Tewari D., and Field H.J. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells. Vet. Microbiol. 46 (1995) 193-201